Linezolid Granule, For Suspension
Product Images NDC 31722-865

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 31722-865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Linezolidfigure (Linezolidfigure)

Linezolidfigure (Linezolidfigure)
A line graph depicting plasma concentration of linezolid over 12 hours following a 600 mg oral dose every 12 hours. The x-axis represents time after dose in hours, and the y-axis shows linezolid plasma concentration in micrograms per milliliter, illustrating the pharmacokinetic decline over time.*
FDA Label Image

Linezolidstructure (Linezolidstructure)

Linezolidstructure (Linezolidstructure)
Chemical structure of Linezolid, showing its molecular framework including the morpholine ring, fluorophenyl group, and oxazolidinone core with an acetamide substituent.*
FDA Label Image

Linezolid-carton-label (Linezolid Carton Label)

Linezolid-carton-label (Linezolid Carton Label)
Packaging label for Linezolid for Oral Suspension 100 mg/5 mL, a granule for suspension oral drug by Camber Pharmaceuticals, Inc. The label shows the NDC 31722-865-25, a 150 mL constituted volume, and important handling instructions including storage at controlled room temperature and mixing directions. Contact information and manufacturing details for Camber Pharmaceuticals and Annora Pharma Pvt. Ltd. are included.*
FDA Label Image

Linezolid-cntr-label (Linezolid Cntr Label)

Linezolid-cntr-label (Linezolid Cntr Label)
Label for Linezolid Oral Suspension, 100 mg/5 mL granules for suspension, manufactured by Camber Pharmaceuticals, Inc. The label includes preparation and storage instructions for the 150 mL constituted suspension, a warning that the product is not for injection, and contact information. It notes mixing directions and storage conditions to protect from light and moisture.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.